Access Statistics for Simona Gamba

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Audit publicity and tax compliance: a quasi-natural experiment 0 0 0 65 2 2 13 149
COVID-19: $R_0$ is lower where outbreak is larger 0 0 0 12 0 0 10 58
COVID-19: R0 is lower where outbreak is larger 0 0 0 29 2 3 10 132
Free-Riding in Pharmaceutical Price Regulation: Theory and Evidence 1 1 3 157 5 7 38 433
Is Tax Compliance a Social Norm? A Field Experiment 0 0 0 251 6 6 24 700
Lies have long legs. Cheating, public scrutiny and loyalty in teams 0 0 1 44 62 62 83 242
My Poor(er) Friend: (Non-)Economic Integration in Public Good Games 0 0 1 17 1 2 20 56
My Poor(er) Friend: (Non-)Economic Integration in Public Good Games 0 0 2 24 1 3 27 78
Optimizing Tax Administration Policies with Machine Learning 0 0 1 267 0 1 23 720
R&D and market size: who benefits from orphan drug regulation? 0 0 0 76 2 4 15 213
Spillovers of Pharmaceutical Price Regulations: evidence from the AMNOG Reform in Germany 0 0 5 29 0 3 30 100
The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector 0 0 0 26 3 4 29 159
The Impact of Social Pressure on Tax Compliance: a Field Experiment 0 0 0 89 1 2 22 152
The Italian Blitz: a natural experiment on audit publicity and tax compliance 0 0 0 67 2 4 16 107
The effect of Intellectual Property Rights on domestic innovation in the pharmaceutical sector 0 0 0 72 1 2 14 137
What exactly is public in a public good game? A lab-in-the-field experiment 0 0 3 159 6 8 22 390
When the two ends meet: an experiment on cooperation across the Italian North-South divide 0 0 0 95 1 3 31 186
Total Working Papers 1 1 16 1,479 95 116 427 4,012


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
An experimental manipulation of divisibility in the public good game 0 0 1 1 1 1 8 8
Audit Publicity and Tax Compliance: A Natural Experiment 0 0 0 17 3 3 14 102
Biomed Europa: After the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly 0 0 0 6 1 5 18 55
COVID-19: R0 is lower where outbreak is larger 0 0 0 3 1 1 15 32
Lies have long legs cheating, peer scrutiny and loyalty in teams 0 0 0 4 4 5 9 32
Machine learning and the optimization of prediction-based policies 0 0 3 8 3 4 26 47
R&D and market size: Who benefits from orphan drug legislation? 0 0 1 5 0 3 21 53
R&D investments, financing constraints, exporting and productivity 0 0 2 59 2 3 24 190
The 2023 European Commission proposal and the 2024 European Parliament proposal for the EU pharmaceutical legislation: policy content analysis 0 1 4 4 1 2 16 16
The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector 0 0 0 20 2 3 19 134
The Price of National Pharmaceutical Pricing in the EU: A Proposal for “Common Procurement” 0 0 0 0 0 0 0 0
The impact of cost-sharing on prescription drug demand: evidence from a double-difference regression kink design 1 1 1 3 3 3 9 17
The impact of managed entry agreements on pharmaceutical prices 0 0 0 16 2 3 19 102
The impact of social pressure on tax compliance: A field experiment 0 1 3 29 1 2 14 141
When the two ends meet: an experiment on cooperation and social capital 0 1 2 8 2 5 25 56
Total Journal Articles 1 4 17 183 26 43 237 985


Statistics updated 2026-11-12